covaxin

New Delhi: India has finally got its vaccine against coronavirus. Two vaccines — Pune-based Serum Institute’s Covishield and Bharat Biotech's Covaxin — received emergency use approval from the Drugs Controller General of India (DCGI) on…

New Delhi: The All India Drug Action Network (AIDAN) has asked the Drugs Controller General of India (DCGI) to reconsider SEC recommendation in granting REU approval to Bharat Biotech-developed COVAXIN. According to the AIDAN, it is…

New Delhi: A day after the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) recommended granting permission for emergency use of the Oxford vaccine, the expert panel on Saturday gave…

Hyderabad: COVID-19 vaccine, Covaxin will be effective in treating the new strain that has created a panic worldwide, Bharat Biotech said on Tuesday. According to Bharat Biotech Chairman and Managing Director Krishna Ella, the protein…

New Delhi: India will require funding of Rs 80,000 crore for distribution of the COVID vaccine for the next one year, said Serum Institute of India, which has partnered with AstraZeneca to manufacture the Oxford-AstraZeneca vaccine, ZeeNews…

New Delhi: Serum Institute of India (SII) and Bharat Biotech have not been granted emergency use authorisation of their coronavirus vaccine because of inadequate safety and efficacy data. According to sources, a panel of experts have asked…

Hyderabad: Pfizer and the Serum Institute of India (SII) had already sought emergency use approval for their COVID-19 vaccines from the Drug Controller General of India (DCGI). Now, Hyderabad-based Bharat Biotech followed suit in urging…

Ambala: Haryana Health Minister Anil Vij has tested positive for coronavirus days after after he was administered a trial dose of coronavirus vaccine Covaxin. Taking to Twitter on Saturday, Vij said that those who have come in close…

New Delhi: With last-stage trials beginning this month, the Indian government-backed COVID-19 vaccine could be launched in February. Since studies so far show that it is safe and effective, it could come months earlier than expected…

Hyderabad: Bharat Biotech's vaccine Covaxin is expected to be launched in Q2 of 2021 pending approvals from authorities. The phase 3 trials will be started at the earliest across the nation, according to reports. Covaxin has been…